APO RESEARCH · REPORT
Vinblastinesulphate
Vinblastinesulphate (CAS 143-67-9) is a white or light yellow amorphous power, which is easily soluble in water. Vinblastine belongs to the group of cancer-fighting medications known as antineoplastics. Vinblastine is used alone or in combination with other antineoplastic medications to treat many different types of cancer including Hodgkin's disease, non-Hodgkin's lymphoma (cancer of the lymph cells), Kaposi's sarcoma, breast cancer, and testicular cancer. It kills cancer cells by interfering with the genetic material DNA, which is necessary for their growth and reproduction.
Product & engineering
Understand the product.
Vinblastinesulphate (CAS 143-67-9) is a white or light yellow amorphous power, which is easily soluble in water. Vinblastine belongs to the group of cancer-fighting medications known as antineoplastics. Vinblastine is used alone or in combination with other antineoplastic medications to treat many different types of cancer including Hodgkin's disease, non-Hodgkin's lymphoma (cancer of the lymph cells), Kaposi's sarcoma, breast cancer, and testicular cancer. It kills cancer cells by interfering with the genetic material DNA, which is necessary for their growth and reproduction.
Selected research
Market Structure
Global Vinblastinesulphate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Vinblastinesulphate (CAS 143-67-9) is a white or light yellow amorphous power, which is easily soluble in water. Vinblastine belongs to the group of cancer-fighting medications known as antineoplastics. Vinblastine is used alone or in combination with other antineoplastic medications to treat many different types of cancer including Hodgkin's disease, non-Hodgkin's lymphoma (cancer of the lymph cells), Kaposi's sarcoma, breast cancer, and testicular cancer. It kills cancer cells by interfering with the genetic material DNA, which is necessary for their growth and reproduction.
Global Vinblastinesulphate (CAS 143-67-9) key players include Guangzhou Hanfang Pharmaceutical, Hainan Vinca Biological Medicine Technology, Guangzhou Person Pharmaceutical, Hainan Yueyang Biotechnology, etc. Global top four manufacturers hold a share about 60%.
China is the largest market, with a share about 40%, followed by Europe and USA, have a share over 40 percent.
Read the full market overview
In terms of product, 97-98% Vinblastinesulphate is the largest segment, with a share about 60%. And in terms of application, the largest application is Lymphoma, followed by Lung Cancer, Breast & Ovarian Cancer, Leukemia, ect.
The report provides an overview of the global Vinblastinesulphate market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Vinblastinesulphate and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Vinblastinesulphate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Vinblastinesulphate market size, projected growth trends, production technologies, key applications, and end-use industries.
Vinblastinesulphate Segment by Company
Guangzhou Hanfang Pharmaceutical
Hainan Vinca Biological Medicine Technology
Guangzhou Person Pharmaceutical
Hainan Yueyang Biotechnology
Hubei Honch Pharmaceutical
Fine Chemicals Corporation
Hengtengfu Biological Products
Vinkem
Vinblastinesulphate Segment by Type
>98% Vinblastinesulphate
97-98% Vinblastinesulphate
Other
Vinblastinesulphate Segment by Application
Lymphoma
Lung Cancer
Breast & Ovarian Cancer
Leukemia
Other
Vinblastinesulphate Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vinblastinesulphate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vinblastinesulphate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vinblastinesulphate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Vinblastinesulphate market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Vinblastinesulphate industry.
Chapter 3: Detailed analysis of Vinblastinesulphate market competition landscape. Including Vinblastinesulphate manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Vinblastinesulphate by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Vinblastinesulphate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- >98% Vinblastinesulphate
- 97-98% Vinblastinesulphate
- Other
Applications
- Lymphoma
- Lung Cancer
- Breast & Ovarian Cancer
- Leukemia
- Other
Companies covered
- Guangzhou Hanfang Pharmaceutical
- Hainan Vinca Biological Medicine Technology
- Guangzhou Person Pharmaceutical
- Hainan Yueyang Biotechnology
- Hubei Honch Pharmaceutical
- Fine Chemicals Corporation
- Hengtengfu Biological Products
- Vinkem
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Vinblastinesulphate Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Vinblastinesulphate Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Vinblastinesulphate Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Vinblastinesulphate Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Vinblastinesulphate Market Dynamics
- 2.1 Vinblastinesulphate Industry Trends
- 2.2 Vinblastinesulphate Industry Drivers
- 2.3 Vinblastinesulphate Industry Opportunities and Challenges
- 2.4 Vinblastinesulphate Industry Restraints
3 Vinblastinesulphate Market by Manufacturers
- 3.1 Global Vinblastinesulphate Production Value by Manufacturers (2021-2026)
- 3.2 Global Vinblastinesulphate Production by Manufacturers (2021-2026)
- 3.3 Global Vinblastinesulphate Average Price by Manufacturers (2021-2026)
- 3.4 Global Vinblastinesulphate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Vinblastinesulphate Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Vinblastinesulphate Manufacturers, Product Type & Application
- 3.7 Global Vinblastinesulphate Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Vinblastinesulphate Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Vinblastinesulphate Players Market Share by Production Value in 2025
- 3.8.3 2025 Vinblastinesulphate Tier 1, Tier 2, and Tier 3
4 Vinblastinesulphate Market by Type
- 4.1 Vinblastinesulphate Type Introduction
- 4.1.1 >98% Vinblastinesulphate
- 4.1.2 97-98% Vinblastinesulphate
- 4.1.3 Other
- 4.2 Global Vinblastinesulphate Production by Type
- 4.2.1 Global Vinblastinesulphate Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Vinblastinesulphate Production by Type (2021-2032)
- 4.2.3 Global Vinblastinesulphate Production Market Share by Type (2021-2032)
- 4.3 Global Vinblastinesulphate Production Value by Type
- 4.3.1 Global Vinblastinesulphate Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Vinblastinesulphate Production Value by Type (2021-2032)
- 4.3.3 Global Vinblastinesulphate Production Value Market Share by Type (2021-2032)
5 Vinblastinesulphate Market by Application
- 5.1 Vinblastinesulphate Application Introduction
- 5.1.1 Lymphoma
- 5.1.2 Lung Cancer
- 5.1.3 Breast & Ovarian Cancer
- 5.1.4 Leukemia
- 5.1.5 Other
- 5.2 Global Vinblastinesulphate Production by Application
- 5.2.1 Global Vinblastinesulphate Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Vinblastinesulphate Production by Application (2021-2032)
- 5.2.3 Global Vinblastinesulphate Production Market Share by Application (2021-2032)
- 5.3 Global Vinblastinesulphate Production Value by Application
- 5.3.1 Global Vinblastinesulphate Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Vinblastinesulphate Production Value by Application (2021-2032)
- 5.3.3 Global Vinblastinesulphate Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Guangzhou Hanfang Pharmaceutical
- 6.1.1 Guangzhou Hanfang Pharmaceutical Company Information
- 6.1.2 Guangzhou Hanfang Pharmaceutical Business Overview
- 6.1.3 Guangzhou Hanfang Pharmaceutical Vinblastinesulphate Production, Value and Gross Margin (2021-2026)
- 6.1.4 Guangzhou Hanfang Pharmaceutical Vinblastinesulphate Product Portfolio
- 6.1.5 Guangzhou Hanfang Pharmaceutical Recent Developments
- 6.2 Hainan Vinca Biological Medicine Technology
- 6.2.1 Hainan Vinca Biological Medicine Technology Company Information
- 6.2.2 Hainan Vinca Biological Medicine Technology Business Overview
- 6.2.3 Hainan Vinca Biological Medicine Technology Vinblastinesulphate Production, Value and Gross Margin (2021-2026)
- 6.2.4 Hainan Vinca Biological Medicine Technology Vinblastinesulphate Product Portfolio
- 6.2.5 Hainan Vinca Biological Medicine Technology Recent Developments
- 6.3 Guangzhou Person Pharmaceutical
- 6.3.1 Guangzhou Person Pharmaceutical Company Information
- 6.3.2 Guangzhou Person Pharmaceutical Business Overview
- 6.3.3 Guangzhou Person Pharmaceutical Vinblastinesulphate Production, Value and Gross Margin (2021-2026)
- 6.3.4 Guangzhou Person Pharmaceutical Vinblastinesulphate Product Portfolio
- 6.3.5 Guangzhou Person Pharmaceutical Recent Developments
- 6.4 Hainan Yueyang Biotechnology
- 6.4.1 Hainan Yueyang Biotechnology Company Information
- 6.4.2 Hainan Yueyang Biotechnology Business Overview
- 6.4.3 Hainan Yueyang Biotechnology Vinblastinesulphate Production, Value and Gross Margin (2021-2026)
- 6.4.4 Hainan Yueyang Biotechnology Vinblastinesulphate Product Portfolio
- 6.4.5 Hainan Yueyang Biotechnology Recent Developments
- 6.5 Hubei Honch Pharmaceutical
- 6.5.1 Hubei Honch Pharmaceutical Company Information
- 6.5.2 Hubei Honch Pharmaceutical Business Overview
- 6.5.3 Hubei Honch Pharmaceutical Vinblastinesulphate Production, Value and Gross Margin (2021-2026)
- 6.5.4 Hubei Honch Pharmaceutical Vinblastinesulphate Product Portfolio
- 6.5.5 Hubei Honch Pharmaceutical Recent Developments
- 6.6 Fine Chemicals Corporation
- 6.6.1 Fine Chemicals Corporation Company Information
- 6.6.2 Fine Chemicals Corporation Business Overview
- 6.6.3 Fine Chemicals Corporation Vinblastinesulphate Production, Value and Gross Margin (2021-2026)
- 6.6.4 Fine Chemicals Corporation Vinblastinesulphate Product Portfolio
- 6.6.5 Fine Chemicals Corporation Recent Developments
- 6.7 Hengtengfu Biological Products
- 6.7.1 Hengtengfu Biological Products Company Information
- 6.7.2 Hengtengfu Biological Products Business Overview
- 6.7.3 Hengtengfu Biological Products Vinblastinesulphate Production, Value and Gross Margin (2021-2026)
- 6.7.4 Hengtengfu Biological Products Vinblastinesulphate Product Portfolio
- 6.7.5 Hengtengfu Biological Products Recent Developments
- 6.8 Vinkem
- 6.8.1 Vinkem Company Information
- 6.8.2 Vinkem Business Overview
- 6.8.3 Vinkem Vinblastinesulphate Production, Value and Gross Margin (2021-2026)
- 6.8.4 Vinkem Vinblastinesulphate Product Portfolio
- 6.8.5 Vinkem Recent Developments
7 Global Vinblastinesulphate Production by Region
- 7.1 Global Vinblastinesulphate Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Vinblastinesulphate Production by Region (2021-2032)
- 7.2.1 Global Vinblastinesulphate Production by Region (2021-2026)
- 7.2.2 Global Vinblastinesulphate Production Forecast by Region (2027-2032)
- 7.3 Global Vinblastinesulphate Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Vinblastinesulphate Production Value by Region (2021-2032)
- 7.4.1 Global Vinblastinesulphate Production Value by Region (2021-2026)
- 7.4.2 Global Vinblastinesulphate Production Value by Region (2027-2032)
- 7.5 Global Vinblastinesulphate Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Vinblastinesulphate Production Value (2021-2032)
- 7.6.2 Europe Vinblastinesulphate Production Value (2021-2032)
- 7.6.3 Asia-Pacific Vinblastinesulphate Production Value (2021-2032)
- 7.6.4 South America Vinblastinesulphate Production Value (2021-2032)
- 7.6.5 Middle East & Africa Vinblastinesulphate Production Value (2021-2032)
8 Global Vinblastinesulphate Consumption by Region
- 8.1 Global Vinblastinesulphate Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Vinblastinesulphate Consumption by Region (2021-2032)
- 8.2.1 Global Vinblastinesulphate Consumption by Region (2021-2026)
- 8.2.2 Global Vinblastinesulphate Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Vinblastinesulphate Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Vinblastinesulphate Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Vinblastinesulphate Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Vinblastinesulphate Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Vinblastinesulphate Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Vinblastinesulphate Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Vinblastinesulphate Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Vinblastinesulphate Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Vinblastinesulphate Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Vinblastinesulphate Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Vinblastinesulphate Value Chain Analysis
- 9.1.1 Vinblastinesulphate Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Vinblastinesulphate Production Mode & Process
- 9.2 Vinblastinesulphate Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Vinblastinesulphate Distributors
- 9.2.3 Vinblastinesulphate Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst